The new connector incorporates patented technology from ICU Medical that is designed to prevent all types of blood reflux in a catheter, including line or syringe disconnection, patient vascular pressure changes caused by coughing or sneezing, as well as an IV bag running dry all of which are associated with catheter patency.

ICU Medical said that as a neutral-pressure device, the use of the Neutron may help hospitals address FDA concerns about the safety of positive displacement needleless connectors and their possible connection to higher rates of device-associated bloodstream infections (BSI).

In addition to the device’s neutral-pressure features, the Neutron also incorporates a pre-slit septum that was recently noted in the 2010 Draft CDC Guidelines for the Prevention of Intravascular Catheter-Related Infections as being a preferred design feature to aid in the prevention of bloodstream Infections.

Reportedly, based on the death reports associated with BSI and concerns of infection control authorities including the Society for Healthcare Epidemiologists of America and Infectious Disease Society of America, the FDA had ordered manufacturers of positive displacement connectors to conduct a post-market surveillance study on the safety of the devices.

ICU Medical expects to conduct expanded clinical beta testing of the Neutron with select customers in the third quarter of 2010.